Stocksigma LogoStocksigma Logo

ANG Lifesciences Reports Q2 FY27 Loss; Auditor Highlights Loan Defaults and Unpaid Dues

ANG Lifesciences India reported a consolidated net loss of ₹208.85 lakh for Q2 ended 30th Sep'26, compared to a net loss of ₹294.73 lakh in Q2 ended 30th

ANG Lifesciences Reports Q2 FY27 Loss; Auditor Highlights Loan Defaults and Unpaid Dues

ANG Lifesciences India Ltd · Financial Result · 15 Nov 2026, 3:00 am

ANG Lifesciences Reports Q2 FY27 Loss; Auditor Highlights Loan Defaults and Unpaid Dues ANG Lifesciences India reported a consolidated net loss of ₹208.85 lakh for Q2 ended 30th Sep'26, compared to a net loss of ₹294.73 lakh in Q2 ended 30th Sep'25, with revenue from operations declining 22.8% YoY to ₹2,010.03 lakh. For H1 ended 30th Sep'26, consolidated net loss expanded to ₹633.27 lakh on revenue of ₹3,539.80 lakh. Statutory auditors issued an unmodified opinion with Emphasis of Matter detailing ₹494.08 lakh in HDFC Bank loan defaults and unpaid statutory dues of ₹438.88 lakh.

Original exchange filing (PDF)

More announcements from ANG Lifesciences India Ltd

All ANG Lifesciences India Ltd announcements